Grants and Contracts Details


Primary objective: to determine whether the efficacy of stereotactic ventriculo-peritoneal CSF shunting (VPS) with medical therapy is superior to medical therapy alone or optic nerve sheath fenestration (ONSF) with medical therapy in reducing or reversing visual loss in subjects with idiopathic intracranial hypertension and moderate to sever visual loss. Secondary objective: To assess time to treatment failure over up to 3 years.
Effective start/end date7/1/186/30/19


  • Mount Sinai: $2.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.